[CytoReason in PR Newswire] CytoReason Announces Collaboration with Ferring to Identify Novel Therapeutic Targets in Inflammatory Bowel Disease Using AI Technology
TEL AVIV, Israel, May 19, 2021 /PRNewswire/ — CytoReason, an Israeli company developing a computational model of the human body ...